|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CTNNB1-FGF12 (FusionGDB2 ID:20319) |
Fusion Gene Summary for CTNNB1-FGF12 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CTNNB1-FGF12 | Fusion gene ID: 20319 | Hgene | Tgene | Gene symbol | CTNNB1 | FGF12 | Gene ID | 1499 | 2257 |
Gene name | catenin beta 1 | fibroblast growth factor 12 | |
Synonyms | CTNNB|EVR7|MRD19|NEDSDV|armadillo | EIEE47|FGF12B|FHF1 | |
Cytomap | 3p22.1 | 3q28-q29 | |
Type of gene | protein-coding | protein-coding | |
Description | catenin beta-1catenin (cadherin-associated protein), beta 1, 88kDa | fibroblast growth factor 12fibroblast growth factor 12Bfibroblast growth factor FGF-12bfibroblast growth factor homologous factor 1myocyte-activating factor | |
Modification date | 20200327 | 20200315 | |
UniProtAcc | P35222 | P61328 | |
Ensembl transtripts involved in fusion gene | ENST00000471014, ENST00000405570, ENST00000396183, ENST00000349496, ENST00000453024, ENST00000396185, | ENST00000445105, ENST00000264730, ENST00000454309, ENST00000450716, ENST00000430714, ENST00000466144, | |
Fusion gene scores | * DoF score | 19 X 14 X 13=3458 | 12 X 7 X 9=756 |
# samples | 21 | 14 | |
** MAII score | log2(21/3458*10)=-4.04147663597616 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(14/756*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CTNNB1 [Title/Abstract] AND FGF12 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CTNNB1(41241161)-FGF12(192078327), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CTNNB1 | GO:0000209 | protein polyubiquitination | 29374064 |
Hgene | CTNNB1 | GO:0008285 | negative regulation of cell proliferation | 12970740 |
Hgene | CTNNB1 | GO:0030997 | regulation of centriole-centriole cohesion | 18086858 |
Hgene | CTNNB1 | GO:0032355 | response to estradiol | 15304487 |
Hgene | CTNNB1 | GO:0033234 | negative regulation of protein sumoylation | 22155184 |
Hgene | CTNNB1 | GO:0043065 | positive regulation of apoptotic process | 12651860|12970740 |
Hgene | CTNNB1 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 29374064 |
Hgene | CTNNB1 | GO:0043525 | positive regulation of neuron apoptotic process | 19591802 |
Hgene | CTNNB1 | GO:0045893 | positive regulation of transcription, DNA-templated | 12970740|18787224 |
Hgene | CTNNB1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 9065402|11751639|12651860|14660579|18193033 |
Hgene | CTNNB1 | GO:0060070 | canonical Wnt signaling pathway | 10644691|12937339|19187541 |
Hgene | CTNNB1 | GO:0071681 | cellular response to indole-3-methanol | 10868478 |
Hgene | CTNNB1 | GO:0090279 | regulation of calcium ion import | 19996314 |
Hgene | CTNNB1 | GO:1904798 | positive regulation of core promoter binding | 22723415 |
Hgene | CTNNB1 | GO:2000008 | regulation of protein localization to cell surface | 19996314 |
Fusion gene breakpoints across CTNNB1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FGF12 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | UCEC | TCGA-AJ-A2QK | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
ChimerDB4 | UCEC | TCGA-AJ-A2QK-01A | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
Top |
Fusion Gene ORF analysis for CTNNB1-FGF12 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000471014 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000471014 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000471014 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000471014 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-intron | ENST00000471014 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-intron | ENST00000471014 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000405570 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000405570 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000405570 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-3CDS | ENST00000405570 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-intron | ENST00000405570 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
intron-intron | ENST00000405570 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396183 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396183 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396183 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396183 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000396183 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000396183 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000349496 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000349496 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000349496 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000349496 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000349496 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000349496 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000453024 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000453024 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000453024 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000453024 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000453024 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000453024 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396185 | ENST00000445105 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396185 | ENST00000264730 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396185 | ENST00000454309 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-3CDS | ENST00000396185 | ENST00000450716 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000396185 | ENST00000430714 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
5UTR-intron | ENST00000396185 | ENST00000466144 | CTNNB1 | chr3 | 41241161 | + | FGF12 | chr3 | 192078327 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CTNNB1-FGF12 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CTNNB1-FGF12 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CTNNB1 | FGF12 |
FUNCTION: Key downstream component of the canonical Wnt signaling pathway (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). Involved in the regulation of cell adhesion, as component of an E-cadherin:catenin adhesion complex (By similarity). Acts as a negative regulator of centrosome cohesion (PubMed:18086858). Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization (PubMed:21262353). Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2 (PubMed:18957423). Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed:22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity). Involved in chondrocyte differentiation via interaction with SOX9: SOX9-binding competes with the binding sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling (By similarity). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18957423, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22647378, ECO:0000269|PubMed:22699938}. | FUNCTION: Involved in nervous system development and function. Involved in the positive regulation of voltage-gated sodium channel activity. Promotes neuronal excitability by elevating the voltage dependence of neuronal sodium channel SCN8A fast inactivation. {ECO:0000269|PubMed:27164707}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CTNNB1-FGF12 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CTNNB1-FGF12 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CTNNB1-FGF12 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CTNNB1 | P35222 | DB03904 | Urea | Small molecule | Approved|Investigational | |
Hgene | CTNNB1 | P35222 | DB03904 | Urea | Small molecule | Approved|Investigational | |
Hgene | CTNNB1 | P35222 | DB03904 | Urea | Small molecule | Approved|Investigational | |
Hgene | CTNNB1 | P35222 | DB03904 | Urea | Small molecule | Approved|Investigational |
Top |
Related Diseases for CTNNB1-FGF12 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CTNNB1 | C0007102 | Malignant tumor of colon | 9 | CTD_human |
Hgene | CTNNB1 | C0009375 | Colonic Neoplasms | 9 | CTD_human |
Hgene | CTNNB1 | C3554449 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 19 | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | CTNNB1 | C0009402 | Colorectal Carcinoma | 5 | CTD_human;UNIPROT |
Hgene | CTNNB1 | C2239176 | Liver carcinoma | 5 | CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | CTNNB1 | C0009404 | Colorectal Neoplasms | 4 | CTD_human |
Hgene | CTNNB1 | C0001418 | Adenocarcinoma | 3 | CTD_human |
Hgene | CTNNB1 | C0019207 | Hepatoma, Morris | 3 | CTD_human |
Hgene | CTNNB1 | C0019208 | Hepatoma, Novikoff | 3 | CTD_human |
Hgene | CTNNB1 | C0023904 | Liver Neoplasms, Experimental | 3 | CTD_human |
Hgene | CTNNB1 | C0086404 | Experimental Hepatoma | 3 | CTD_human |
Hgene | CTNNB1 | C0205641 | Adenocarcinoma, Basal Cell | 3 | CTD_human |
Hgene | CTNNB1 | C0205642 | Adenocarcinoma, Oxyphilic | 3 | CTD_human |
Hgene | CTNNB1 | C0205643 | Carcinoma, Cribriform | 3 | CTD_human |
Hgene | CTNNB1 | C0205644 | Carcinoma, Granular Cell | 3 | CTD_human |
Hgene | CTNNB1 | C0205645 | Adenocarcinoma, Tubular | 3 | CTD_human |
Hgene | CTNNB1 | C0206711 | Pilomatrixoma | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | CTNNB1 | C1879526 | Aberrant Crypt Foci | 3 | CTD_human |
Hgene | CTNNB1 | C0001430 | Adenoma | 2 | CTD_human |
Hgene | CTNNB1 | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
Hgene | CTNNB1 | C0023903 | Liver neoplasms | 2 | CTD_human |
Hgene | CTNNB1 | C0025149 | Medulloblastoma | 2 | CGI;CTD_human;UNIPROT |
Hgene | CTNNB1 | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
Hgene | CTNNB1 | C0027708 | Nephroblastoma | 2 | CTD_human |
Hgene | CTNNB1 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Hgene | CTNNB1 | C0036341 | Schizophrenia | 2 | PSYGENET |
Hgene | CTNNB1 | C0205646 | Adenoma, Basal Cell | 2 | CTD_human |
Hgene | CTNNB1 | C0205647 | Follicular adenoma | 2 | CTD_human |
Hgene | CTNNB1 | C0205648 | Adenoma, Microcystic | 2 | CTD_human |
Hgene | CTNNB1 | C0205649 | Adenoma, Monomorphic | 2 | CTD_human |
Hgene | CTNNB1 | C0205650 | Papillary adenoma | 2 | CTD_human |
Hgene | CTNNB1 | C0205651 | Adenoma, Trabecular | 2 | CTD_human |
Hgene | CTNNB1 | C0235874 | Disease Exacerbation | 2 | CTD_human |
Hgene | CTNNB1 | C0345904 | Malignant neoplasm of liver | 2 | CTD_human |
Hgene | CTNNB1 | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human |
Hgene | CTNNB1 | C0678222 | Breast Carcinoma | 2 | CTD_human |
Hgene | CTNNB1 | C1140680 | Malignant neoplasm of ovary | 2 | CGI;CTD_human;UNIPROT |
Hgene | CTNNB1 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Hgene | CTNNB1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | CTNNB1 | C2930471 | Bilateral Wilms Tumor | 2 | CTD_human |
Hgene | CTNNB1 | C4539767 | EXUDATIVE VITREORETINOPATHY 7 | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | CTNNB1 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Hgene | CTNNB1 | C0000772 | Multiple congenital anomalies | 1 | CTD_human |
Hgene | CTNNB1 | C0001624 | Adrenal Gland Neoplasms | 1 | CTD_human |
Hgene | CTNNB1 | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Hgene | CTNNB1 | C0007528 | Cecal Neoplasms | 1 | CTD_human |
Hgene | CTNNB1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | CTNNB1 | C0007873 | Uterine Cervical Neoplasm | 1 | CTD_human |
Hgene | CTNNB1 | C0010276 | Craniopharyngioma | 1 | CTD_human;ORPHANET |
Hgene | CTNNB1 | C0014518 | Toxic Epidermal Necrolysis | 1 | CTD_human |
Hgene | CTNNB1 | C0016059 | Fibrosis | 1 | CTD_human |
Hgene | CTNNB1 | C0018923 | Hemangiosarcoma | 1 | CTD_human |
Hgene | CTNNB1 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | CTNNB1 | C0021841 | Intestinal Neoplasms | 1 | CTD_human |
Hgene | CTNNB1 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | CTNNB1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | CTNNB1 | C0026846 | Muscular Atrophy | 1 | CTD_human |
Hgene | CTNNB1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | CTNNB1 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | CTNNB1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Hgene | CTNNB1 | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
Hgene | CTNNB1 | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human |
Hgene | CTNNB1 | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
Hgene | CTNNB1 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | CTNNB1 | C0153437 | Malignant neoplasm of cecum | 1 | CTD_human |
Hgene | CTNNB1 | C0206624 | Hepatoblastoma | 1 | CGI;CTD_human |
Hgene | CTNNB1 | C0206669 | Hepatocellular Adenoma | 1 | CTD_human |
Hgene | CTNNB1 | C0206686 | Adrenocortical carcinoma | 1 | CTD_human |
Hgene | CTNNB1 | C0232347 | No-Reflow Phenomenon | 1 | CTD_human |
Hgene | CTNNB1 | C0239946 | Fibrosis, Liver | 1 | CTD_human |
Hgene | CTNNB1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | CTNNB1 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Hgene | CTNNB1 | C0270948 | Neurogenic Muscular Atrophy | 1 | CTD_human |
Hgene | CTNNB1 | C0278875 | Adult Craniopharyngioma | 1 | CTD_human |
Hgene | CTNNB1 | C0279606 | Childhood Hepatocellular Carcinoma | 1 | ORPHANET |
Hgene | CTNNB1 | C0279607 | Adult Hepatocellular Carcinoma | 1 | ORPHANET |
Hgene | CTNNB1 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1 | CTD_human |
Hgene | CTNNB1 | C0339539 | Familial Exudative Vitreoretinopathy | 1 | ORPHANET |
Hgene | CTNNB1 | C0342649 | Vascular calcification | 1 | CTD_human |
Hgene | CTNNB1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | CTNNB1 | C0346627 | Intestinal Cancer | 1 | CTD_human |
Hgene | CTNNB1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Hgene | CTNNB1 | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
Hgene | CTNNB1 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Hgene | CTNNB1 | C0431128 | Papillary craniopharyngioma | 1 | CTD_human |
Hgene | CTNNB1 | C0431129 | Adamantinous Craniopharyngioma | 1 | CTD_human |
Hgene | CTNNB1 | C0431350 | Primary microcephaly | 1 | GENOMICS_ENGLAND |
Hgene | CTNNB1 | C0600519 | Ventricular Remodeling | 1 | CTD_human |
Hgene | CTNNB1 | C0600520 | Left Ventricle Remodeling | 1 | CTD_human |
Hgene | CTNNB1 | C0750887 | Adrenal Cancer | 1 | CTD_human |
Hgene | CTNNB1 | C0751061 | Craniopharyngioma, Child | 1 | CTD_human |
Hgene | CTNNB1 | C0751958 | Lymphoma, Lymphocytic, Intermediate | 1 | CTD_human |
Hgene | CTNNB1 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | CTNNB1 | C0919267 | ovarian neoplasm | 1 | CGI;CTD_human |
Hgene | CTNNB1 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | CTNNB1 | C1274933 | Drug-Induced Stevens Johnson Syndrome | 1 | CTD_human |
Hgene | CTNNB1 | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human |
Hgene | CTNNB1 | C1535926 | Neurodevelopmental Disorders | 1 | CTD_human |
Hgene | CTNNB1 | C1623038 | Cirrhosis | 1 | CTD_human |
Hgene | CTNNB1 | C1851402 | Exudative vitreoretinopathy 1 | 1 | ORPHANET |
Hgene | CTNNB1 | C2713615 | Slow-Flow Phenomenon | 1 | CTD_human |
Hgene | CTNNB1 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | CTNNB1 | C3658301 | Mycoplasma-Induced Stevens-Johnson Syndrome | 1 | CTD_human |
Hgene | CTNNB1 | C3658302 | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1 | CTD_human |
Hgene | CTNNB1 | C4048328 | cervical cancer | 1 | CTD_human |
Hgene | CTNNB1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | CTNNB1 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Tgene | FGF12 | C4310685 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | FGF12 | C0019209 | Hepatomegaly | 1 | CTD_human |
Tgene | FGF12 | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |